Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasms 4cMET-dysregulated Advanced Solid Tumors 1Solid Tumours 1Prostatic Neoplasms 1Pain 1Ovarian Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Gastrointestinal Stromal Tumors 1Fatigue 1Diverticulitis 1Confusion 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Anxiety Disorders 1

Interventions

capmatinib 2Rosuvastatin Calcium 1Midazolam 1Digoxin 1Caffeine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × cMET-dysregulated Advanced Solid Tumors × Caffeine × Clear all
NCT02520752 2020-12-10

A DDI Study to Assess the Effect of INC280 on the PK of Midazolam and Caffeine in Patients With cMET-dysregulated Advanced Solid Tumors

Novartis

Phase 1 Completed
37 enrolled
Other solid neoplasm

cMET-dysregulated Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡